Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 60/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed with results

Key Signals

2 with results88% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (3)
P 1 (1)
P 2 (3)

Trial Status

Completed7
Terminated1
Unknown1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (9)

Research Network

Activity Timeline